HM15275

HM15275
Clinical data
Drug classGLP-1 receptor agonist
Identifiers
CAS Number

HM15275 is an experimental drug that works as a GLP-1, GIP, and glucagon receptor agonist. It is developed by Hanmi Pharmaceutical.[1]

References

  1. ↑ Macias Pulido, Alejandra; Hompesch, Marcus (20 June 2025). "1980-LB: Safety, Tolerability, and Pharmacokinetics of HM15275, a Novel GLP-1, GIP, and Glucagon Triple Receptor Agonist—Preliminary Results from a Phase 1 Study". Diabetes. 74 (Supplement_1). doi:10.2337/db25-1980-LB.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.